TMMPG GROUP-TMMPG GROUP,Medical,Health

MORE +

向下滚动鼠标

ABOUT US

TMMPG

CONCENTRIC CARE

TIANJIN TMMPG CO., LTD.

ABOUT US

Meilun Pharmaceutical Group was founded in 1993 and is a modern, diversified, and international high-tech enterprise group mainly engaged in medical, scientific research, manufacturing of traditional Chinese and Western medicine, cultivation and extraction of traditional Chinese medicine, research and production of natural plant cosmetics, real estate development and construction, international trade, and overseas direct sales. The registered capital of the enterprise is 600 million yuan, and the total assets exceed 6 billion yuan. Meilun Pharmaceutical Group is one of the first batch in Tianjin to undertake heavy responsibilities

Know More +

PRODUCTS

TMMPG

CONCENTRIC CARE

Andrographis paniculata dropping pills

Ingredients: this product contains each ingredient citrate injection, torvalds 25 milligrams, Lin excipents of paraffin wax, stearic acid < BR > category: this product is a cough class over-the-counter medicines Indications: applicable to have no phlegm cough symptoms of disease, acute bronchitis, chronic bronchitis and cough due to a variety of causes can be used Usage and dosage: oral, adult 1 pill each time, 3 to 4 times a day, the dosage of children should consult physician or pharmacist

Houjiling Capsules

this product contains each ingredient citrate injection, torvalds 25 milligrams, Lin excipents of paraffin wax, stearic acid < BR > category: this product is a cough class over-the-counter medicines Indications: applicable to have no phlegm cough symptoms of disease, acute bronchitis, chronic bronchitis and cough due to a variety of causes can be used Usage and dosage: oral, adult 1 pill each time, 3 to 4 times a day, the dosage of children should consult physician or pharmacist

Indapamide dropping pills

category: this product is a cough class over-the-counter medicines Indications: applicable to have no phlegm cough symptoms of disease, acute bronchitis, chronic bronchitis and cough due to a variety of causes can be used Usage and dosage: oral, adult 1 pill each time, 3 to 4 times a day, the dosage of children should consult physician or pharmacist

Fuwei San Capsule

this product is a cough class over-the-counter medicines Indications: applicable to have no phlegm cough symptoms of disease, acute bronchitis, chronic bronchitis and cough due to a variety of causes can be used Usage and dosage: oral, adult 1 pill each time, 3 to 4 times a day, the dosage of children should consult physician or pharmacist

NEWS CENTER

TMMPG

CONCENTRIC CARE

2019/01/18

Emergency measures for aloe vera poisoning

Aloe vera is one of the traditional Chinese medicines for purgation and defecation. Aloe is a perennial herb of Liliaceae, with light Orange-red flowers in summer and autumn. There are Cape of Good Hope aloe (produced in Africa), Curacao aloe (produced in South America) and striped aloe (produced in southern provinces and regions of China), which are Poisonous plants in southern China. The whole aloe contains the toxic ingredients aloin and aloin (aloe emodin).

2019/01/18

Fundamentals of Drug R&D and Drug Technology Review

Drug research and development and drug technology review are different stages of drug registration, both serving to ensure the safety and effectiveness of drug research and production, but with different service targets. Drug research and development serves drug registration applicants, while drug technical evaluation serves the national drug registration and approval authorities. Both require support from drug registration information. Drug registration information can generally be divided into: (1) Drug registration regulations and policy information, including the Drug Administration Law, the Implementation Regulations of the Drug Administration Law, the Drug Registration Management Measures, as well as relevant policy documents and guiding principles issued by the National Bureau. (2) Drug application and registration information,

2019/01/18

Drug Research and Development: Promoting the Development of Natural Plant Medicines

After completing the development of the anticancer drug Gleevec (STI571), researchers found that this drug is also effective for a disease with a relatively poor prognosis: acute myeloid leukemia (AML). Researchers have identified two new drugs that can effectively inhibit the specific enzymes produced by AML. Scientists say these two new drugs are PKC412 and CT53518, respectively, and the research report was published in the June medical journal Cancer Cell. Harvard Medical School